Trulieve Cannabis Corp. (NYSE: TRLV) announced that Chairman and CEO Kim Rivers has notified the broker-dealer administering her automatic securities disposition plan (ASDP) of her intention to terminate the plan during the company's next open trading window on August 11, 2026. The ASDP, adopted on March 16, 2026, was established under Rule 10b5-1 of the Securities Exchange Act of 1934 and provided for the orderly sale of 2.5 million shares in two tranches.
First Tranche Completed
Sales under the first tranche began on June 17, 2026, and as of June 26, 2026, a total of 1,699,007 subordinate voting shares have been sold. The second tranche was scheduled to start on September 15, 2026, but Rivers' termination of the plan will prevent any further sales under that tranche.
Forward-Looking Statements
The company noted that forward-looking statements in the release are subject to risks and uncertainties detailed in its Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent filings with the SEC and SEDAR+. Trulieve assumes no obligation to update these statements.
About Trulieve
Trulieve is a vertically integrated cannabis company and multi-state operator with medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. The company is listed on the NYSE under the symbol TRLV.
